LOGIN
Tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee
August 2013
Tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: A randomized, double-blind, dose-escalation, placebo-controlled study
Osteoarthritis Cartilage; 2011;19(12):1405-1412Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
83 Japanese patients with moderate to severe osteoarthritis of the knee were randomized to receive either tanezumab 10, 25, 50, 100 or 200 mg/kg or a placebo. The results from 120 day follow-up indicated that stronger doses of tanezumab result in significantly better pain relief in comparison to baseline measurements. However, the results from the study also indicated that adverse events occurred ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.